-Christopher P Evans Researcher Activity Profile

Research Author Detailed Information 

Christopher P Evans Publication Rate By Year

Christopher P Evans has published 1 paper(s) in 2006, 12 paper(s) in 2007, 6 paper(s) in 2008, for a total of 19 research publications in total.

Christopher P Cp Evans Author Information

LAST NAME: evans

FIRST NAME: Christopher P

INITIALS: cp

AFFILIATION:

Papers

Christopher P Evans's Publication Record

1. Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation. Year Published: 2007
University of California, Davis, CA, USA.
2. Clinical implications of neuroendocrine differentiation in prostate cancer. Year Published: 2007
Department of Urology, Davis Medical Center, University of California at Davis, Sacramento, CA 95817, USA.
3. Renal cell carcinoma: current status and emerging therapies. Year Published: 2007
Department of Urology, University of California, Davis Medical Center, Sacramento, CA 95817, USA. enelson06m@gmail.com
4. Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications. Year Published: 2007
Department of Urology, University of California, Davis Medical Center, 4860 Y St, Suite 3500, Sacramento, CA 95817, USA. enelson06m@gmail.com
5. Year Published: 2007
Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA, USA. christopher.evans@ucdmc.ucdavis.edu
6. Inhibition of Akt pathways in the treatment of prostate cancer. Year Published: 2007
1Department of Urology, University of California at Davis, Sacramento, CA, USA.
7. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Year Published: 2007
Departments of Urology and Biochemistry and Molecular Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817.
8. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Year Published: 2007
Departments of Urology and Biochemistry and Molecular Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA.
9. Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications. Year Published: 2007
Department of Urology, University of California, Davis Medical Center, 4860 Y St, Suite 3500, Sacramento, CA 95817, USA. enelson06m@gmail.com
10. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Year Published: 2007
Departments of Urology and Biochemistry and Molecular Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA.
11. Managing prostate cancer: the role of hormone therapy. Year Published: 2007
Department of Urology and Cancer Center, University of California at Davis, Sacramento, CA 95817, USA.
12. Current management of small renal masses. Year Published: 2007
Department of Urology and Cancer Center, University of California at Davis, Sacramento, CA 95817, USA.
13. The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial. Year Published: 2008
University of California Davis Cancer Center, Sacramento.
14. Efficacy of transhepatic radiofrequency ablation of renal cell carcinoma. Year Published: 2006
Department of Radiology, University of California, Davis, Medical Center, Sacramento, CA 95817, USA.
15. The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial. Year Published: 2008
University of California Davis Cancer Center, Sacramento, CA 95817, USA.
16. Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). Year Published: 2008
Department of Urology [A.J.C., C.P.E.], University of California Davis, Sacramento, CA, USA.
17. Non-surgical management of multicystic dysplastic kidney. Year Published: 2008
Department of Urology, University of California, Davis School of Medicine, Sacramento, CA 95817, USA.
18. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Year Published: 2008
Department of Medical Oncology, Bern University Hospital, Bern, Switzerland. oliver.gautschi@insel.ch
19. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Year Published: 2008
Department of Medical Oncology, Bern University Hospital, Bern, Switzerland. oliver.gautschi@insel.ch